EUROMACS Right Ventricular Failure (RHF) Risk Score Calculator
Risk assessment
Enter preoperative variables for patients being evaluated for continuous-flow LVAD implantation.
This score estimates risk of early severe right heart failure after LVAD implantation. It is an adjunct to multidisciplinary clinical assessment, not a standalone decision rule.
| Variable | Entered value | Points |
|---|---|---|
| Score breakdown will appear after calculation. | ||
Risk estimates are cohort-level estimates from the derivation study and may not be calibrated to a particular centre or contemporary LVAD population.
About the EUROMACS-RHF score
The EUROMACS Right-Sided Heart Failure score was developed to estimate early (within 30 days) severe right-sided heart failure after continuous-flow LVAD implantation. The published preoperative score uses five variables; cardiopulmonary bypass time is not part of this preoperative score.
Scoring criteria
| Variable | Criterion | Points |
|---|---|---|
| RAP/PCWP ratio | >0.54 | +2 |
| Hemoglobin | ≤10 g/dL | +1 |
| Intravenous inotropes | Multiple agents; implementation threshold currently ≥3 | +2.5 |
| INTERMACS profile | 1–3 | +2 |
| Severe RV dysfunction | Present on preoperative echocardiography | +2 |
Risk groups
| Score | Category | Reported early RHF risk |
|---|---|---|
| 0–2 | Low | Approximately 11% |
| >2–4 | Intermediate | Approximately 25–28% (reported across cohorts) |
| >4 | High | Up to approximately 43% |
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.